Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02220426Phase 1Terminated
Phase 1, open-label, single-arm trial of xenon in obesity, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Brown Adipose Tissue Surface Area at Day 1. Started Sep 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02220426.